Beruflich Dokumente
Kultur Dokumente
ABSTRACT
Snakes are the most despised animals in the world. Ample narrations about snakes are avail-
able in Brihattrayee. Snake venom, though greatly feared, is a natural biological resource, containing
several components that could be of potential therapeutic value. The therapeutic use of snake venom
is mentioned since ancient time for different diseases. It is well known that snake venom is complex
mixture of enzymes, peptides and proteins of low molecular mass with specific chemical and bio-
logical activities. Snake venom contains several neurotoxic, cardiotoxic, cytotoxic enzymes, nerve
growth factor, lectins, disintrigrins, haemorrhagins and many other different enzymes. These proteins
not only inflict death to animals and humans, but can also be used for the treatment of thrombosis,
arthritis, cancer and many other diseases. An overview of various snake venom components that
have prospects with the advent of biotechnology, the efficacy of such treatments has been substanti-
ated by purifying components of venom and delineating their therapeutic properties Snake venom
toxins contributed significantly to the treatment of many medical conditions. This paper will focus
on certain snake venom components and their applications in health and disease, diagnosis and
treatment.
Key words: Snake venom, toxins, therapeutic, enzymes.
INTRODUCTION
Snake venom is highly mod- commensurate with poison to neutralize the
ified saliva. It is a clear and viscous fluid [1] poison [3]. Now many researches are done on
which contains zootoxins that facilitates the snake venom. This thing is very well known
immobilization and digestion of prey, and de- by our ancient Acharyas thats why they use
fends against a threat. . Snake venom, though snake venom for the therapeutic purposes.
greatly feared, is a natural biological resource, Application of snake venom toxins in health
containing several components that could be and diseases have been mentioned in folk-
of potential therapeutic value. It is injected by medicine [4]. Snake venom shows activity
unique fangs after a bite but some species are against various experimental pathology, ani-
also able to spit [2]. The snake venom when mal studies such as cancer [5&6], stroke[7], neu-
injected then it is poisonous but when it is ral trauma, Alzheimers disease, Parkinsons
consumed orally then it is not poisonous. The disease[8], Anti-arthritic activity.
wise physician should treat the patient of oral Ironically, the properties that make
poisoning by snake bite. There is nothing to venom deadly are also what make it so valu-
How to cite this URL: Chaitanya R Baraskar & Waghaye Ramesh: A Critical Review On Therapeutic Use Of Snake Venom
International Ayurvedic medical Journal {online} 2016 {cited 2016 December} Available from:
http://www.iamj.in/posts/images/upload/3667_3673.pdf
Chaitanya R Baraskar & Waghaye Ramesh: A Critical Review On Therapeutic Use Of Snake Venom
able for medicine, Jennifer Holland writes for Physical character of Snake venom [10]
National Geographic. Many venom toxins Colour of snake venom clear and vis-
target the same molecules that need to be con- cous fluid of amber color, yellow color or
trolled to treat disease. Venom works fast and straw color, The color of sea snake venom is
is highly specific. Its active components colorless. The viscosity of extracted venom
those peptides and proteins, working as toxins shows seasonal variation. Winter venom is
and enzymes target particular molecules, smaller in quantity & more viscous when
fitting into them like keys into locks [9]. compared with that obtained in summer sea-
Thousands of animals are venomous son. It is acidic reaction and specific gravity of
from snakes, scorpions, spiders, and bees to ranges from 1.030 to 1.070.
lizards, octopuses, fish, and snails. Out of Collection and storage of Snake venom [11]
these snakes venom is important. Researchers The venom is collected from the fangs
still havent studied or unleashed all the me- of snake. The snake is made to bite on some
dicinal properties of snake venoms. Snake object and venom is collected in glass jar. The
venom is seething with various toxins, pro- venom can be dried to needle like crystal
teins, molecules, and enzymes that could po- forms. It can be freeze dried in a container
tentially be used to treat diseases. packed with ice. By this the potency of venom
Aim & Objectives:- is kept intact.
To study the therapeutic uses of snake venom. Constituents of venom
Material and Methods:- Venom is composed of number of sub-
References of snake venom and its stances. In the snake itself it is reserved out-
therapeutic use has been collected from Ay- side its circulation and physiological sphere of
urveda texts as well as from modern text and body, confined to venom gland and duct. So
internet. All the data were compiled, analysed snakes also suffer from hazards of toxic ef-
and discussed through and in depth under- fects of bite of other venomous snakes.
standing of therapeutic use of snake venom
which is mention in Ayurveda and modern sci-
ence.
Table 1: Constituents of Snake venom
Non-Enzymatic Fractions EnzymaticFractions Other coagulation factors
Neurotoxic polypeptide (NT) Phospholipase A Haemorrhagins
Cobravenom cardiotoxin Proteases Exo and endopeptidases
Crotalid neurotoxin Amino acid esterases Phophatases
Crotalid neurotoxin Lamino Acid Oxidases
Hyaluronidase
Acetyl choline esterases
There are two main types of venom:- In India, antivenins are prepared from horses.
1) Hemotoxins:-Hemotoxins target the circu- Monospecific serum is prepared using the
latory system. They prevent clotting com- venom of a single snake. Polyspecific serum is
pounds from functioning correctly, which prepared by using venom of more than one
causes uncontrollable bleeding. snake. This is prepared at Haffkine Institute,
2) Neurotoxins: - Neurotoxins target the cen- Mumbai and Central research Institute, Ka-
tral nervous system. They stop muscles from sauli. It is in the form of a lyophilized powder
working, which leads to suffocation. of horse serum produced by immunization of
Therapeutic uses of snake venom (Accord- hporses with the venom of four snakes,
ing to Modern)[12] namely, common cobra, common krait, Rus-
The most important decision in the sels viper amnd saw-scaled viper.
management of the patient bitten by a snake is Indication for antivenom therapy may in-
whether or not given antivenom. Most com- clude:
mercial antivenom is of equine origin and car- Haemostatic abnormalities such as spontane-
ries a risk of anaphylactic, anaphylactoid and ous systemic bleeding, incoagulable blood or
delayed hypersensitivity reactions. Skin test- thrombocytopenia.
ing dose not reliably predict which patients Hypotension and shock, abnormal ECG or
will have an allergic reactions to equine other evidence of cardiovascular dysfunction.
antivenom. False negative and false positive Neurotoxicity and generalized rhabdomyoly-
result may be there. Therefore, appropriate sis.
loading doses of intravenous antihistamines Supporting evidence of severe envenoming
and cimetidine may be given in an effort to includes neutrophilic leucocytosis, elevated
limit acute reactions. Epinephrine should be serum enzymes like creatine, phosphokinase
immediately available. It is almost never too and aminotransferases, haemoconcentration ,
late to give antivenom while signs of systemic myoglobunuria, haemoglobinuria , methaemo-
envenoming persist, but ideally, it should be globinuria, hypoxemia and acidosis.
given as soon as it is indicated. antiveom has Tender enlargement of the local lymph nodes
proved effective up to 2days after hydrophid usually indicates a systemic spread.
bites and in a patients still defibrinated, weeks It is used for research and therapeutic pur-
after bite by viperidae. In contrast, local en- poses.
venoming is probably not reversible unless The scientific research & development
antivenom is given within a few hours of the with snake venom has focused on diverse
bite. Intravenous rout is the most effective, physiological & biochemical processes
and it should be administered after dilution, like Coagulation cascade system, Vasoac-
rather than intravenous push. tive kinin system, Transport across cell
Initially, the infusion may be regulated membranes, Nerve excitation studies,
at 15-20 drops per minute. The rate can be Structure of phospholipids & nucleic ac-
progressively increased so that the infusion is ids.
complicated in 1-2 hours. Being with 8-10 vi- Therapeutically major use of snake venom
als and check for improvement. It is advisable is preparation of anti snake venom.
to wait for 6hours and perform investigations. Arvin, an active coagulant principle (ami-
if there is no significant improvement addi- no-acid esterase) of malyanam pitviper is
tional 5-8 vials can be given ion continuing available for commercial use as a anticoa-
absence of improvement. gulant in ischemic heart diseases.
www.iamj.in IAMJ: Volume 4; Issue 12; December- 2016
3669
Chaitanya R Baraskar & Waghaye Ramesh: A Critical Review On Therapeutic Use Of Snake Venom
dian king cobra venom which possesses an- More than 40 formulations of snake ve-
tiarrhythmic properties at microgram level15. nom are mentioned in Ayurveda for man-
Use of ancrod has also been reported succes- agement of various diseases. The efficacy
sive in cardiac catheterization and coronary and safety of such formulations should be
artery bypass grafting. In antineoplastic activ- studied hence, researches are needed in
ity of snake venom, it has been showed that this context , to prove the potency of for-
Indian cobra venoms cytotoxic to Ehrlich as- mulation of snake venom.
cites tumor cells. Therapeutic use of cobra ve- REFERENCES
nom is in cancer and arthritis15. Rhodopsin an 1. "Reptile Venom Research". Australian
arg-gly-asp containing anti-platelet snake ve- Reptile Park. Retrieved 21 Decem-
nom peptide served as an inhibitory agent in ber 2010.
the prevention of thrombin enhanced metasta- 2. J.K. Lalla, Sunita Ogale, Priyanka Gos-
sis. In antineoplastic activity of snake venom, wami, Zaid Temrikar, Geeta Talele, Snake
neurotoxins from snake venoms have been Bite Problem in India: An Overview,
utilized in different pharmacological and bio- H.K.College Of Pharma-
chemical studies of nicotinic acetylcholine re- cy,Jogeshwari(W),Mumbai, 400102.
ceptors (nAChr) in the neuron and neuromus- 3. Dr. P.Srinivas Rao, Astanga Samgra-
cular junction [16]. Use of snake venom toxin to ha,(Uttara-sthana) Vol.-3, , Chapter No.48/
identify AChR & their antibodies permitted Verse 6,Edition-1,2009, Choukhamba
both the purification & understanding of pa- krishnadas Prakashan, Varanasi, page
thological mechanism impairing neuromuscu- no.454.
lar transmission in Myasthenia gravis [16]. 4. Pal S K, Gomes A, Dasgupta S C &
Haemotoxins, in snake venom target the circu- Gomes A, Snake venom as therapeutic
latory system, and typically attack the bodys agents ; from Toxins to drug development,
clotting ability & muscles. But scientist has Indian J Exp Biol, 40 (2002) 1353.
also found ways to use haemotoxins for medi- 5. Das T, Bhattacharya S, Haldar B , Biswas
cine, such as treating heart attacks & blood A , Dasgupta S, Gomes A, Cytotoxic &
disorder. Other drugs have been developed antioxidant properties of purified fraction
from neurotoxins in snake venom, which used (NH-32) of India Naja naja venom on Eh-
to treat Parkinsons & brain injuries. Due to its rlich ascites carcinoma in BALB/c mice,
wide use it is necessary to do researches on Toxicon, 57 (2011) 1065.
snake venom as a therapeutic agent 6. Gomes A , Bhattacharjee P, Mishra R,
Biswas A K , Dasgupta S C & Giri B, An-
CONCLUSION ticancer potential of animal venoms and
Snake venom toxin may serve as a starting toxins , Indian J Exp Biol, 48 (2010) 93.
material for a drug design to combat sev- 7. Sherman D G , Atkinson R P, Chippendale
eral patho physiological problems such as T, Levin A K, Ng K, Futrell N, Hsu C Y
cardiovascular disorder, Neurological & Levy D E, Intravenous Ancrod for
problems, Cancer therapy. treatment o acute ischemic stroke : the
Very few clinical studies are available & STAT study: A randomized controlled trial
there is need for extensive research pro- Stroke treatment Ancrod Trial, JAMA,
grams to work out the above mention 283(2000) 2461.
areas. 8. Koh D C I, Armugam A & Jeyaseelan K,
Snake venom components 7 their applica-
www.iamj.in IAMJ: Volume 4; Issue 12; December- 2016
3672
Chaitanya R Baraskar & Waghaye Ramesh: A Critical Review On Therapeutic Use Of Snake Venom